Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages


Articles: Stomach/GI



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7
Journal of Hepatology, 06/10/09
Sponsor
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
Journal of Hepatology, 06/10/09
Arbaclofen Placarbil, A Novel R-Baclofen Prodrug: Improved ADME Properties Compared to R-Baclofen
Journal of Pharmacology and Experimental Therapeutics, 06/10/09
Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells
Liver International, 06/10/09
Efficacy of Sumatriptan in Two Pediatric Cases With Abdominal Pain-Related Functional Gastrointestinal Disorders: Does the Mechanism Overlap That of Migraine
Journal of Child Neurology, 06/10/09
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841
Journal of Clinical Oncology, 06/10/09
Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment
Journal of Gastroenterology and Hepatology, 06/09/09
Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease
Inflammatory Bowel Disease, 06/09/09
Bioactivation of Minocycline to Reactive Intermediates by Myeloperoxidase, Horseradish Peroxidase and Hepatic Microsomes: Implications for Minocycline-Induced Lupus and Hepatitis
Drug Metabolism and Disposition, 06/09/09
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?
Biologics: targets & therapy, 06/08/09    Free full text
Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries
Expert Opinion in Pharmacotherapy, 06/08/09
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose
Digestive and Liver Diseases, 06/08/09
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
Amgen, 06/08/09    Free full text
Ceftriaxone-induced toxic hepatitis
World Journal of Gastroenterology, 06/08/09    Free full text
The anti-ulcer activities of bisabolangelone from Angelica polymorpha
Journal of Ethnopharmacology, 06/05/09
Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines
PharmacoEconomics, 06/05/09    Clinical Guideline
Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients
Clinical Pharmacology & Therapeutics, 06/05/09
Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients
Drug Metabolism and Disposition, 06/04/09
3-Ketocholanoic Acid Is The Major In Vitro Human Hepatic Microsomal Metabolite of Lithocholic Acid
Drug Metabolism and Disposition, 06/04/09
Exclusive Author Commentary
Sorafenib and Vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms
Molecular Pharmacology, 06/04/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    15      16      17      18      19      20      21      22      23      24      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.